Methodological and Statistical Comments on CASPIAN-III Study

authors:

avatar Ali Kabir 1 , *

Department of Epidemiology, Faculty of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Hepatitis Monthly: Vol.13, issue 5; e10161
published online: May 25, 2013
article type: Letter
received: January 7, 2013
accepted: February 6, 2013
DOI: https://doi.org/10.5812/hepatmon.10161

how to cite: Kabir A. Methodological and Statistical Comments on CASPIAN-III Study. Hepat Mon. 2013;13(5):e10161. https://doi.org/10.5812/hepatmon.10161.

References

  • 1.

    Kelishadi R, Abtahi SH, Qorbani M, Heshmat R, Esmaeil Motlagh M, Taslimi M, et al. First National Report on Aminotransaminases' Percentiles in Children of the Middle East and North Africa (MENA): the CASPIAN-III Study. Hepat Mon. 2012;12(11). [PubMed ID: 23346152]. https://doi.org/10.5812/hepatmon.7711.

  • 2.

    Kelishadi R, Heshmat R, Motlagh ME, Majdzadeh R, Keramatian K, Qorbani M, et al. Methodology and Early Findings of the Third Survey of CASPIAN Study: A National School-based Surveillance of Students' High Risk Behaviors. Int J Prev Med. 2012;3(6):394-401. [PubMed ID: 22783465].

  • 3.

    Poustchi H, George J, Esmaili S, Esna-Ashari F, Ardalan G, Sepanlou SG, et al. Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. PLoS One. 2011;6(6). [PubMed ID: 21738618]. https://doi.org/10.1371/journal.pone.0021178.

  • 4.

    Szklo M, Nieto FJ. Epidemiology: beyond the basics. Jones and Bartlett Publishers; 2012.